| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |